Koronis Pharmaceuticals
{{Short description|American biotechnology company}}
{{No footnotes|date=August 2018}}
{{Infobox company
| industry = Biotechnology
| founded = {{start date and age|1998}}
}}
Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection. The company also has products in development for the treatment of hepatitis C and RSV infection.
References
{{refbegin}}
- {{Citation |title=U.S. HIV drug firm Koronis looks to London listing |first=Ben |last=Hirschler |url=https://www.reuters.com/article/us-koronis-hiv/u-s-hiv-drug-firm-koronis-looks-to-london-listing-idUSTRE72C1AX20110313 |work=Reuters }}
- {{Citation |title= Koronis' HIV drug draws funding; $20 million to be used for studies |first=John |last=Cook |date=June 28, 2007 |url= https://www.seattlepi.com/news/article/Koronis-HIV-drug-draws-funding-1242160.php |newspaper=Seattle P-I }}
- {{Citation |url= https://www.forbes.com/forbes/2011/0808/focus-hiv-biotech-koronis-pandemic-drug-embracing-enemy.html#1afb122d73df |magazine=Forbes |title= Embracing The Enemy |first=Kerry A. |last=Dolan |date=July 20, 2011 }}
- {{Citation |title= Biotech pioneer Gillis ventures into a new field |first=John |last=Cook |date=August 2, 2005 |url= https://www.seattlepi.com/business/article/Biotech-pioneer-Gillis-ventures-into-a-new-field-1179674.php |newspaper=Seattle P-I }}
- Paulson, Tom. "Conflicts Advance a Burgeoning Field Industry, Academia Now are Bedfellows." Seattle P-I. May 19, 1999: A1.
- Biotech Industry Driven By Evolution Searching For Cures, Companies Get Creative. Carol Smith P-I Reporter. Seattle P-I. May 17, 1999: A1.
- Mature companies beat out new ones for VC cash. Romano, Benjamin J. Seattle Times. October 25, 2005: C1.
- {{Citation |title= Darwin's Surprise |first=Michael |last=Specter |magazine=The New Yorker |volume= 83 |issue=38 |date=December 3, 2007 |pages=64– }}
- {{Citation |url=https://www.popsci.com/node/205298 |title=The new virus killer: scientists try to turn HIV's greatest strength--mutation--against itself. |first=Gregory |last=Mone |magazine=Popular Science |volume=274 |issue=2 |date=February 2009 |pages= 27– }}
{{refend}}
External links
- {{Official website|http://www.koronispharma.com}}
- Reuters story on IPO prospects [https://www.reuters.com/article/us-koronis-hiv-idUSTRE72C1AX20110313]
Category:Biotechnology companies of the United States
Category:Companies based in Seattle
{{med-company-stub}}